Arrowhead Pharmaceuticals
ARWR
#2176
Rank
S$11.00 B
Marketcap
S$79.62
Share price
-4.98%
Change (1 day)
166.74%
Change (1 year)

Arrowhead Pharmaceuticals (ARWR) - Cash on Hand

Cash on Hand as of June 2025 : S$1.16 Billion

According to Arrowhead Pharmaceuticals 's latest financial reports the company has S$1.16 Billion in cash and cash equivalents.
A companyโ€™s cash on hand also refered as cash/cash equivalents (CCE) and Short-term investments, is the amount of accessible money a business has.

Arrowhead Pharmaceuticals - Cash on Hand chart (from 1999 to 2025)

Cash on Hand by year

Year Cash on Hand Change
2024-09-30S$0.87 B58.7%
2023-09-30S$0.55 B2.06%
2022-09-30S$0.54 B8.15%
2021-09-30S$0.49 B16.02%
2020-09-30S$0.43 B20.41%
2019-09-30S$0.35 B241.7%
2018-09-30S$0.10 B17.35%
2017-09-30S$89.17 M-23.44%
2016-09-30S$0.11 B-17.15%
2015-09-30S$0.14 B-28.53%
2014-09-30S$0.19 B456.81%
2013-09-30S$35.32 M725.09%
2012-09-30S$4.28 M-59.51%
2011-09-30S$10.57 M17.42%
2010-09-30S$9 M214.94%
2009-09-30S$2.85 M-80.28%
2008-09-30S$14.5 M-59.27%
2007-09-30S$35.61 M-19.97%
2006-09-30S$44.49 M16.78%
2005-09-30S$38.1 M150.76%
2004-09-30S$15.19 M548.61%
2003-09-30S$2.34 M7027.43%
2002-09-30S$0.03 M6770.98%
2001-09-30S$0 M-85.91%
2000-09-30S$0 M1511.37%
1999-09-30S$0 M-87.74%
1998-09-30S$0 M-3.61%
1997-09-30S$0 M

Cash on Hand for similar companies or competitors

Company Cash on Hand differencediff. Country
Alnylam Pharmaceuticals
ALNY
S$3.53 B 202.61%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
N/AN/A๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
S$0.87 B-24.82%๐Ÿ‡บ๐Ÿ‡ธ USA
Inovio Pharmaceuticals
INO
S$65.83 M-94.36%๐Ÿ‡บ๐Ÿ‡ธ USA
Johnson & Johnson
JNJ
S$24.05 B 1,961.59%๐Ÿ‡บ๐Ÿ‡ธ USA
Moderna
MRNA
S$5.83 B 400.24%๐Ÿ‡บ๐Ÿ‡ธ USA